UY34629A - Inhibidores de pirazolopirimidinilo de enzima activadora de ubicuitina - Google Patents

Inhibidores de pirazolopirimidinilo de enzima activadora de ubicuitina

Info

Publication number
UY34629A
UY34629A UY0001034629A UY34629A UY34629A UY 34629 A UY34629 A UY 34629A UY 0001034629 A UY0001034629 A UY 0001034629A UY 34629 A UY34629 A UY 34629A UY 34629 A UY34629 A UY 34629A
Authority
UY
Uruguay
Prior art keywords
ubicuitin
activating enzyme
pyrazolopyrimidinyl
inhibitors
pyrazolopyrimidinyl inhibitors
Prior art date
Application number
UY0001034629A
Other languages
English (en)
Spanish (es)
Inventor
Afroze Roushan
Indu T Bharathan
Jeffrey P Ciavarri
Paul E Fleming
Jeffrey L Gaulin
Girard Mario
Steven P Langston
Francois R Soucy
Tzu-Tshin Wong
Ye Yingchun
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of UY34629A publication Critical patent/UY34629A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
UY0001034629A 2012-02-17 2013-02-15 Inhibidores de pirazolopirimidinilo de enzima activadora de ubicuitina UY34629A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261600070P 2012-02-17 2012-02-17

Publications (1)

Publication Number Publication Date
UY34629A true UY34629A (es) 2013-09-02

Family

ID=48982730

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034629A UY34629A (es) 2012-02-17 2013-02-15 Inhibidores de pirazolopirimidinilo de enzima activadora de ubicuitina

Country Status (30)

Country Link
US (4) US9290500B2 (https=)
EP (3) EP2814791A4 (https=)
JP (1) JP6122877B2 (https=)
KR (1) KR20140123104A (https=)
CN (1) CN104136399B (https=)
AR (1) AR092797A1 (https=)
BR (1) BR112014020365B1 (https=)
CA (1) CA2864672C (https=)
CL (1) CL2014002181A1 (https=)
CO (1) CO7071135A2 (https=)
CR (1) CR20140380A (https=)
DO (1) DOP2014000187A (https=)
EA (1) EA035020B1 (https=)
EC (1) ECSP14019113A (https=)
ES (1) ES2739150T3 (https=)
GE (1) GEP201706687B (https=)
HK (1) HK1201817A1 (https=)
IL (1) IL234016A0 (https=)
MA (1) MA35932B1 (https=)
MX (1) MX352963B (https=)
NZ (1) NZ628969A (https=)
PE (1) PE20142244A1 (https=)
PH (1) PH12014501832A1 (https=)
SG (2) SG10201606581RA (https=)
TN (1) TN2014000351A1 (https=)
TW (1) TWI593688B (https=)
UA (1) UA116534C2 (https=)
UY (1) UY34629A (https=)
WO (1) WO2013123169A1 (https=)
ZA (1) ZA201406103B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
EP2814791A4 (en) 2012-02-17 2015-08-19 Millennium Pharm Inc PYRAZOLOPYRIMIDINYL INHIBITORS OF ACTIVATION ENZYME OF UBIQUITIN
EP2879681A4 (en) 2012-08-03 2015-12-23 Millennium Pharm Inc INDOINDUBSTITUTED PYRROLOPYRIMIDINYL HIBITORS OF UBA6
JP6378759B2 (ja) 2013-07-02 2018-08-22 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Sumo活性化酵素阻害剤として有用なヘテロアリール化合物
SG11201610476VA (en) 2014-07-01 2017-01-27 Millennium Pharm Inc Heteroaryl compounds useful as inhibitors of sumo activating enzyme
JP6697453B2 (ja) * 2014-10-29 2020-05-20 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. ユビキチン活性化酵素阻害物質及び放射線の投与
WO2016069392A1 (en) 2014-10-29 2016-05-06 Millennium Pharmaceuticals, Inc. Administration of ubiquitin-activating enzyme inhibitor and chemotherapeutic agents
AU2019370200B2 (en) 2018-10-30 2024-12-19 Kronos Bio, Inc. Compounds, compositions, and methods for modulating CDK9 activity
WO2022253188A1 (en) * 2021-05-31 2022-12-08 Impact Therapeutics (Shanghai) , Inc Nitrogen-containing fused heteroaromatic bicyclic compounds as usp1 inhibitors and the use thereof
WO2023021498A1 (en) * 2021-08-16 2023-02-23 Moya Bio Ltd. Fused azole and furan based nucleoside analogs and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003073989A2 (en) 2002-02-28 2003-09-12 Biota, Inc. Nucleoside 5'-monophosphate mimics and their prodrugs
US7196092B2 (en) 2002-09-04 2007-03-27 Schering Corporation N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
US7563798B2 (en) 2002-09-04 2009-07-21 Schering Corporation Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
MY137843A (en) 2002-09-04 2009-03-31 Schering Corp Pyrazolopyrimidines as cyclin dependent kinase inhibitors
CA2497444C (en) 2002-09-04 2010-11-30 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
US20070179161A1 (en) 2003-03-31 2007-08-02 Vernalis (Cambridge) Limited. Pyrazolopyrimidine compounds and their use in medicine
JP2005008581A (ja) * 2003-06-20 2005-01-13 Kissei Pharmaceut Co Ltd 新規なピラゾロ[1,5−a]ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
US20050130974A1 (en) 2003-10-17 2005-06-16 Rigel Pharmaceuticals, Inc. Benzothiazole compositions and their use as ubiquitin ligase inhibitors
WO2006002284A1 (en) 2004-06-22 2006-01-05 Rigel Pharmaceuticals, Inc. Ubiquitin ligase inhibitors
RS52458B (sr) 2005-02-04 2013-02-28 Millennium Pharmaceuticals Inc. Inhibitori e1 aktivirajućih enzima
TWI333953B (en) 2005-10-06 2010-12-01 Schering Corp Pyrazolopyrimidines as protein kinase inhibitors
EA024006B1 (ru) 2006-02-02 2016-08-31 Миллениум Фармасьютикалз, Инк. Ингибиторы е1 активирующих ферментов
EP1992008A1 (en) * 2006-02-28 2008-11-19 Sez Ag Device and method for liquid treating disc-like articles
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
ZA200900670B (en) * 2006-08-08 2010-04-28 Millennium Pharm Inc Heteroaryl compounds useful as inhititors of E1 activating enzymes
JP5539864B2 (ja) 2007-06-12 2014-07-02 アカオゲン,インコーポレーテッド 抗菌剤
EP2178880B1 (en) 2007-08-02 2017-10-04 Millennium Pharmaceuticals, Inc. Process for the synthesis of e1 activating enzyme inhibitors
US9216983B2 (en) 2007-12-21 2015-12-22 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
WO2010086040A1 (en) 2009-01-29 2010-08-05 Biomarin Iga, Ltd. Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
WO2010088518A2 (en) 2009-01-31 2010-08-05 Kalypsys, Inc. Heterocyclic modulators of gpr119 for treatment of disease
EP2430026A1 (en) 2009-05-14 2012-03-21 Millennium Pharmaceuticals, Inc. Hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
MX2012010115A (es) 2010-03-01 2013-02-26 Gtx Inc Compuestos para el tratamiento de cancer.
US20120077814A1 (en) 2010-09-10 2012-03-29 Zhong Wang Sulfonamide, sulfamate, and sulfamothioate derivatives
JP6038150B2 (ja) 2011-08-24 2016-12-07 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Nedd8活性化酵素阻害剤
EP2814791A4 (en) 2012-02-17 2015-08-19 Millennium Pharm Inc PYRAZOLOPYRIMIDINYL INHIBITORS OF ACTIVATION ENZYME OF UBIQUITIN
EP2879681A4 (en) 2012-08-03 2015-12-23 Millennium Pharm Inc INDOINDUBSTITUTED PYRROLOPYRIMIDINYL HIBITORS OF UBA6
JP6378759B2 (ja) 2013-07-02 2018-08-22 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Sumo活性化酵素阻害剤として有用なヘテロアリール化合物
SG11201610476VA (en) 2014-07-01 2017-01-27 Millennium Pharm Inc Heteroaryl compounds useful as inhibitors of sumo activating enzyme

Also Published As

Publication number Publication date
MX352963B (es) 2017-12-15
CO7071135A2 (es) 2014-09-30
DOP2014000187A (es) 2014-10-15
EP3173413A1 (en) 2017-05-31
CN104136399B (zh) 2018-08-07
JP6122877B2 (ja) 2017-04-26
ECSP14019113A (es) 2015-09-30
EP2814791A4 (en) 2015-08-19
CL2014002181A1 (es) 2014-12-12
EP3536692A1 (en) 2019-09-11
NZ628969A (en) 2017-03-31
US9290500B2 (en) 2016-03-22
EA035020B1 (ru) 2020-04-17
AR092797A1 (es) 2015-05-06
MX2014009944A (es) 2014-11-10
SG10201606581RA (en) 2016-09-29
BR112014020365A2 (pt) 2020-12-22
TWI593688B (zh) 2017-08-01
BR112014020365B1 (pt) 2023-02-23
HK1201817A1 (en) 2015-09-11
PH12014501832A1 (en) 2014-11-17
JP2015508775A (ja) 2015-03-23
US20170217968A1 (en) 2017-08-03
EA201400831A1 (ru) 2014-12-30
ZA201406103B (en) 2017-11-29
WO2013123169A1 (en) 2013-08-22
US20130217682A1 (en) 2013-08-22
EP3536692B1 (en) 2021-04-07
GEP201706687B (en) 2017-06-26
PE20142244A1 (es) 2015-01-07
US20160244455A1 (en) 2016-08-25
EP3173413B1 (en) 2019-05-01
TW201345909A (zh) 2013-11-16
CR20140380A (es) 2014-10-28
EP2814791A1 (en) 2014-12-24
CN104136399A (zh) 2014-11-05
SG11201404757WA (en) 2014-09-26
CA2864672A1 (en) 2013-08-22
US9796725B2 (en) 2017-10-24
TN2014000351A1 (en) 2015-12-21
IL234016A0 (en) 2014-09-30
US9663525B2 (en) 2017-05-30
MA35932B1 (fr) 2014-12-01
CA2864672C (en) 2018-01-09
KR20140123104A (ko) 2014-10-21
UA116534C2 (uk) 2018-04-10
US20140088096A9 (en) 2014-03-27
US20170369499A1 (en) 2017-12-28
US10202389B2 (en) 2019-02-12
ES2739150T3 (es) 2020-01-29

Similar Documents

Publication Publication Date Title
UY34824A (es) Nucleósidos de espirooxetano de uracilo
UY34765A (es) Compuestos novedosos.
UY34472A (es) Derivados modificados de 4-fenil-piridina
UY34778A (es) ?COMPUESTOS DE HEXAHIDROPIRANO[3,4-d][1,3]TIAZIN-2-AMINA HETEROCÍCLICOS SUSTITUÍDOS?.
UY34820A (es) Compuestos tipo pirrolo-pirrolidinona
UY34559A (es) Inhibidores de bromodominios
UY34591A (es) Compuestos de imidazopirrolidinona
UY34302A (es) COMPUESTOS DE HEXAHIDROPIRANO[3,4-d][1,3]TIAZIN-2- AMINA
UY34629A (es) Inhibidores de pirazolopirimidinilo de enzima activadora de ubicuitina
UY34515A (es) Triazolopiridinas sustituidas
UY34393A (es) Compuestos de tetrahidroisoquinolina sustituidos como inhibidores del factor xia
UY34763A (es) Inhibidores de la agregación plaquetaria
UY34445A (es) Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a
UY34374A (es) Benzilindazoles sustituidos
UY34550A (es) Bencilpirazoles sustituidos
MX378288B (es) Inhibidores de pirimidina del fgfr4.
UY34648A (es) Amidas como inhibidores de pim
UY34817A (es) Tienopirimidinas
UY34145A (es) Compuestos inhibidores de metaloenzimas
UY34146A (es) Compuestos inhibidores de metaloenzimas
UY34697A (es) Métodos para preparar análogos de nucleótidos
UY34632A (es) Compuestos de oxazolidin- 2- ona y usos de los mismos
UY34804A (es) Inhibidores del nampt
UY34352A (es) 3-pirimidin-4-il-oxazolidin-2-onas como inhibidores de la idh mutante
UY34767A (es) Inhibidores cíclicos del enlace éter de dgat1

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20210526